Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee
Links shared publicly online about this topic.
- 953total visits
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee
View full resource at medicalnewstoday.com
Tags: Drug, Pharma, FDA, GlaxoSmithKline, Epilepsy Medication
Most Recently Shared on August 12, 2010 at 4:50 pm By:
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee: GlaxoSmithK... http://mnt.to/f/3HhF
Also Shared By:
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee - QualityPoint Technologies
qualitypointtech.net — “GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced that a U.S. Food and Drug Administration (FDA) advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of ezogabine as adjunctive treatment for adults with partial-onset seizures. After a review of the safety data, including urinary retention, infection and kidney stones, the majority of Committee members voted that urinary retention could be mitig” View full resource at qualitypointtech.net
Most Recently Shared on August 12, 2010 at 1:45 pm By:
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee: GlaxoSmithK... http://bit.ly/cCPMNX
Advertisement
medical_tweets
@medical_tweets
Ezogabine, An Investigational Anti-Epileptic Drug, Receives Positive Vote From FDA Advisory Committee GlaxoSmithKline (.. http://dld.bz/r4Mx
1 year ago...